BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27818121)

  • 1. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
    Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
    Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
    Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of APOBEC3B in mutation induction by irradiation.
    Saito Y; Miura H; Takahashi N; Kuwahara Y; Yamamoto Y; Fukumoto M; Yamamoto F
    J Radiat Res; 2020 Nov; 61(6):819-827. PubMed ID: 32880638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis.
    Wu J; Li N; Zhu L; Zhen D; Li M; Chen H; Ye M; Wei Y; Shao G
    BMC Bioinformatics; 2022 Aug; 23(1):312. PubMed ID: 35918642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers.
    Argyris PP; Wilkinson PE; Jarvis MC; Magliocca KR; Patel MR; Vogel RI; Gopalakrishnan R; Koutlas IG; Harris RS
    Mod Pathol; 2021 Feb; 34(2):280-290. PubMed ID: 32632179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
    Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
    Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
    PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.
    Chen TW; Lee CC; Liu H; Wu CS; Pickering CR; Huang PJ; Wang J; Chang IY; Yeh YM; Chen CD; Li HP; Luo JD; Tan BC; Chan TEH; Hsueh C; Chu LJ; Chen YT; Zhang B; Yang CY; Wu CC; Hsu CW; See LC; Tang P; Yu JS; Liao WC; Chiang WF; Rodriguez H; Myers JN; Chang KP; Chang YS
    Nat Commun; 2017 Sep; 8(1):465. PubMed ID: 28878238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
    Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
    Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
    Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
    Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
    Tokunaga E; Yamashita N; Tanaka K; Inoue Y; Akiyoshi S; Saeki H; Oki E; Kitao H; Maehara Y
    PLoS One; 2016; 11(12):e0168090. PubMed ID: 27977754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma.
    Dos Reis PP; Bharadwaj RR; Machado J; Macmillan C; Pintilie M; Sukhai MA; Perez-Ordonez B; Gullane P; Irish J; Kamel-Reid S
    Cancer; 2008 Dec; 113(11):3169-80. PubMed ID: 18991282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3B: pathological consequences of an innate immune DNA mutator.
    Burns MB; Leonard B; Harris RS
    Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear to cytoplasmic shift of p33(ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables.
    Zhang JT; Wang DW; Li QX; Zhu ZL; Wang MW; Cui DS; Yang YH; Gu YX; Sun XF
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):421-6. PubMed ID: 17805569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for APOBEC3B mutagenesis in multiple human cancers.
    Burns MB; Temiz NA; Harris RS
    Nat Genet; 2013 Sep; 45(9):977-83. PubMed ID: 23852168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
    Verhalen B; Starrett GJ; Harris RS; Jiang M
    J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines.
    Onguru O; Yalcin S; Rosemblit C; Zhang PJ; Kilic S; Gunduz U
    Biomed Pharmacother; 2016 Apr; 79():87-92. PubMed ID: 27044816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.